The forecasted growth in scientific publications in Endocrinology, Diabetes, and Metabolism from 2024 to 2028 in China shows a robust increasing trend. Starting from 5.27 thousand publications in 2024, the forecast projects a steady year-on-year growth, reaching 8.81 thousand by 2028. Given that the data from 2023 is not provided, the precise year-on-year variations cannot be computed. However, based on the provided data, the sector is experiencing a compound annual growth rate (CAGR) over this period.
Future trends to watch for include increased emphasis on healthcare innovations and collaborations in research, which could further stimulate this upward trajectory. Continued government funding and private investments are also crucial factors likely to influence this segment’s growth.
